薬剤溶出バルーン市場：タイプ、コーティング技術、エンドユーザー別-2025～2030年の世界予測

薬剤溶出バルーン市場は、2023年に9億6,584万米ドルと評価され、2024年には10億9,831万米ドルに達すると予測され、CAGR 15.51%で成長し、2030年には26億5,047万米ドルに達すると予測されています。

薬剤溶出バルーン（DEB）は、主にインターベンショナルカーディオロジーセグメントで使用される医療機器です。DEBは、従来の血管形成術用バルーンの機械的特徴と薬剤溶出の薬学的利点を併せ持ち、血管疾患の治療に革新的なソリューションを記載しています。DEB市場は、心血管疾患の有病率の上昇、低侵襲手技に関する意識の高まり、医療機器の技術進歩によって牽引されています。冠動脈疾患や末梢動脈疾患の治療では、抗増殖薬を患部に直接投与することで再狭窄に対処します。最終用途には病院、外来手術センター、専門クリニックなどが含まれ、DEBの需要を大きく牽引しています。

同市場は、世界の高齢化の進展とそれに伴う慢性疾患の増加により、有望な成長ポテンシャルを示しています。薬剤製剤の改良と使いやすいデリバリーメカニズムに重点を置いた革新的な製品設計により、潜在的なビジネス機会を活用することができます。医療インフラが徐々に改善しつつある新興市場に参入することで、さらなる市場拡大が可能です。しかし、規制状況の厳しさや、手技や製品開発にかかるコストの高さが主要制約となっています。また、バルーンの滑りやドラッグデリバリーの一貫性の欠如といった技術的課題も成長の妨げとなっています。

イノベーションは、薬剤放出の有効性を高め、DEBを介して送達可能な薬剤の範囲を拡大することに向けられるべきです。技術的な障壁を克服するための解決策を開発し、製造の費用対効果を向上させることは、研究にとって時宜を得たセグメントです。機器メーカーと製薬企業とのコラボレーションにより、新たな製品開発が促進される可能性があります。市場は依然としてダイナミックであり、強力な競合環境が継続的な成長と適応を促しています。的を絞った調査や戦略的提携を通じてこれらの課題に取り組むことで、利害関係者はDEB市場の軌道に大きな影響を与えることができます。

市場力学：急速に進化する薬剤溶出バルーン市場の主要市場洞察を解明

薬剤溶出バルーン市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネス機会の獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 心血管疾患につながる高齢者の増加
  • 末梢動脈疾患と冠動脈疾患の有病率の上昇
  • DEBの成長を支える有利な承認
• 市場抑制要因
  • 薬剤溶出性バルーンのリコール問題
• 市場機会
  • 薬剤被覆バルーンカテーテルの臨床使用における新展開
  • 薬剤被覆バルーンの進歩、革新、調査
• 市場課題
  • 熟練した専門家の不足

ポーターのファイブフォース：薬剤溶出バルーン市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：薬剤溶出バルーン市場における外部からの影響の把握

外部マクロ環境要因は、薬剤溶出バルーン市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：薬剤溶出バルーン市場における競合情勢の把握

薬剤溶出バルーン市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：薬剤溶出バルーン市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、薬剤溶出バルーン市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限はベンダーを明確かつ正確に区分し、ユーザーが戦略目標に最適なパートナーやソリューションを特定するのに役立ちます。

本レポートは、主要な注目セグメントを網羅した包括的な市場分析を提供しています。

1.市場の浸透度：産業主要企業の広範なデータを含む、現在の市場環境の詳細なレビュー。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 高齢者の増加が心血管疾患につながる
    • 末梢動脈疾患と冠動脈疾患の罹患率の上昇
    • DEBの成長を支える好意的な承認
  • 抑制要因
    • 薬剤溶出バルーンの製品リコールに関連する問題
  • 機会
    • 薬剤コーティングバルーンカテーテルの臨床使用における新たな展開
    • 薬剤コーティングバルーンの進歩、革新、調査
  • 課題
    • 熟練した訓練を受けた専門家の不足
• 市場セグメンテーション分析
  • タイプ：送達性と薬剤移行性の向上における冠動脈DEBの重要性
  • コーティング技術：局所的な薬剤放出プロファイルが優れたenduraCoatの好感度が高まっている
  • エンドユーザー：使いやすさと手順の速さにより、カテーテル検査室でのDEBの採用率が向上
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境
• 顧客のカスタマイズ

第6章 薬剤溶出バルーン市場：タイプ別

• イントロダクション
• 冠動脈薬剤溶出バルーン
• 周辺機器薬剤溶出バルーン

第7章 薬剤溶出バルーン市場：コーティング技術

• イントロダクション
• エンデュラコート
• フリーパック
• パコカス
• トランスパックス

第8章 薬剤溶出バルーン市場：エンドユーザー別

• イントロダクション
• 外来手術センター
• カテーテル検査室
• 病院

第9章 南北アメリカの薬剤溶出バルーン市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋の薬剤溶出バルーン市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの薬剤溶出バルーン市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
  • Advanced NanoTherapies（ANT）が、新規冠動脈疾患（CAD）の治療を目的としたSirPlux Duo薬剤コーティングバルーン（DCB）の臨床開発を加速するために400万米ドルの戦略的投資を確保
  • Translumina、Blue Medical Devicesの買収により技術ポートフォリオをさらに強化
  • SurmodicsがSurVeil薬剤コーティングバルーンのFDA承認を取得

企業一覧

• Medtronic PLC
• Becton, Dickinson and Company
• Boston Scientific Corporation
• M.A. Med Alliance SA by Cordis Corporation
• Eurocor Tech GmbH
• Lepu Medical Technology
• Invamed
• BIoTronik SE & Co. KG
• Cook Medical, Inc.
• Terumo Corporation
• Cardionovum GmbH
• SurModics, Inc.
• Johnson & Johnson Services, Inc.
• Balton Sp. z o. o.
• B. Braun Melsungen AG
• Bayer AG
• Abbott Laboratories
• Wellinq
• Laborie Medical Technologies, Inc.
• Concept Medical
• Zylox-Tonbridge Medical Technology Co., Ltd.
• Biosensors International Group, Ltd.
• Koninklijke Philips N.V.
• iVascular S.L.U.

LIST OF FIGURES

• FIGURE 1. DRUG ELUTING BALLOON MARKET RESEARCH PROCESS
• FIGURE 2. DRUG ELUTING BALLOON MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES DRUG ELUTING BALLOON MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES DRUG ELUTING BALLOON MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. DRUG ELUTING BALLOON MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. DRUG ELUTING BALLOON MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. DRUG ELUTING BALLOON MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. DRUG ELUTING BALLOON MARKET DYNAMICS
• TABLE 7. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY CORONARY DRUG ELUTING BALLOON, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY PERIPHERAL DRUG ELUTING BALLOON, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY ENDURACOAT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY FREEPAC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY PACCOCATH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY TRANSPAX, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY CATH LABS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 29. CANADA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 30. CANADA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 31. CANADA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES DRUG ELUTING BALLOON MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 46. CHINA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 47. CHINA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 48. CHINA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 49. INDIA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 50. INDIA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 51. INDIA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 101. ITALY DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 102. ITALY DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 103. ITALY DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 113. POLAND DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 114. POLAND DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 115. POLAND DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 116. QATAR DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 117. QATAR DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 118. QATAR DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 146. DRUG ELUTING BALLOON MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 147. DRUG ELUTING BALLOON MARKET, FPNV POSITIONING MATRIX, 2023

The Drug Eluting Balloon Market was valued at USD 965.84 million in 2023, expected to reach USD 1,098.31 million in 2024, and is projected to grow at a CAGR of 15.51%, to USD 2,650.47 million by 2030.

A Drug Eluting Balloon (DEB) is a medical device used primarily in the field of interventional cardiology. It combines the mechanical feature of a traditional angioplasty balloon with the pharmaceutical benefits of drug elution, providing an innovative solution for treating vascular diseases. The DEB market is driven by the rising prevalence of cardiovascular diseases, increasing awareness regarding minimally invasive procedures, and technological advancements in healthcare devices. Crucial to its application are the treatments for coronary artery disease and peripheral artery disease, addressing restenosis by delivering anti-proliferative drugs directly to the affected site. End-use scope includes hospitals, ambulatory surgical centers, and specialized clinics, significantly driving the demand for DEBs.

The market shows promising growth potential, fueled by the increasing global aging population and subsequent rise in chronic disease occurrences. Potential opportunities can be harnessed through innovative product designs focusing on improved drug formulations and user-friendly delivery mechanisms. Further market expansion can be achieved by entering emerging markets where healthcare infrastructure is progressively improving. However, stringent regulatory landscapes and high costs of procedure and product development are key limitations. Technical challenges such as balloon slippage and inconsistent drug delivery also hinder growth.

Innovation should be directed towards enhancing the efficacy of drug release and expanding the range of drugs that can be delivered via DEBs. Developing solutions to overcome technical barriers and improving the cost-effectiveness of production are areas ripe for research. Collaborations between device manufacturers and pharmaceutical companies could foster new product developments. The market remains dynamic, with a strong competitive environment encouraging continuous growth and adaptation. By addressing these challenges through targeted research and strategic collaborations, stakeholders can significantly influence the trajectory of the DEB market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Drug Eluting Balloon Market

The Drug Eluting Balloon Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing Geriatric Population Leading to Cardiovascular Diseases
  • Rising Prevalence of Peripheral and Coronary Artery Diseases
  • Favorable Approvals to Support the Growth of DEBs
• Market Restraints
  • Issues Associated to Product Recalls of Drug-Eluting Balloons
• Market Opportunities
  • New Developments in the Clinical Use of Drug-Coated Balloon Catheters
  • Advancement, Innovation, and Research in Drug-Coated Balloons
• Market Challenges
  • Lack of Availability for Skilled and Trained Professionals

Porter's Five Forces: A Strategic Tool for Navigating the Drug Eluting Balloon Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Drug Eluting Balloon Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Drug Eluting Balloon Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Drug Eluting Balloon Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Drug Eluting Balloon Market

A detailed market share analysis in the Drug Eluting Balloon Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Drug Eluting Balloon Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Drug Eluting Balloon Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Drug Eluting Balloon Market, highlighting leading vendors and their innovative profiles. These include Medtronic PLC, Becton, Dickinson and Company, Boston Scientific Corporation, M.A. Med Alliance SA by Cordis Corporation, Eurocor Tech GmbH, Lepu Medical Technology, Invamed, Biotronik SE & Co. KG, Cook Medical, Inc., Terumo Corporation, Cardionovum GmbH, SurModics, Inc., Johnson & Johnson Services, Inc., Balton Sp. z o. o., B. Braun Melsungen AG, Bayer AG, Abbott Laboratories, Wellinq, Laborie Medical Technologies, Inc., Concept Medical, Zylox-Tonbridge Medical Technology Co., Ltd., Biosensors International Group, Ltd., Koninklijke Philips N.V., and iVascular S.L.U..

Market Segmentation & Coverage

This research report categorizes the Drug Eluting Balloon Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Coronary Drug Eluting Balloon and Peripheral Drug Eluting Balloon.
• Based on Coating Technology, market is studied across EnduraCoat, FreePac, Paccocath, and TransPax.
• Based on End User, market is studied across Ambulatory Surgery Centers, Cath Labs, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing Geriatric Population Leading to Cardiovascular Diseases
    • 5.1.1.2. Rising Prevalence of Peripheral and Coronary Artery Diseases
    • 5.1.1.3. Favorable Approvals to Support the Growth of DEBs
  • 5.1.2. Restraints
    • 5.1.2.1. Issues Associated to Product Recalls of Drug-Eluting Balloons
  • 5.1.3. Opportunities
    • 5.1.3.1. New Developments in the Clinical Use of Drug-Coated Balloon Catheters
    • 5.1.3.2. Advancement, Innovation, and Research in Drug-Coated Balloons
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of Availability for Skilled and Trained Professionals
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Significance of coronary DEBs in enhancing deliverability and drug transfer
  • 5.2.2. Coating Technology: Growing preferences for enduraCoat with better local drug release profile
  • 5.2.3. End User: Higher adoption of DEBs in Cath Labs owing to ease of use and speed of the procedure
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental
• 5.5. Client Customization

6. Drug Eluting Balloon Market, by Type

• 6.1. Introduction
• 6.2. Coronary Drug Eluting Balloon
• 6.3. Peripheral Drug Eluting Balloon

7. Drug Eluting Balloon Market, by Coating Technology

• 7.1. Introduction
• 7.2. EnduraCoat
• 7.3. FreePac
• 7.4. Paccocath
• 7.5. TransPax

8. Drug Eluting Balloon Market, by End User

• 8.1. Introduction
• 8.2. Ambulatory Surgery Centers
• 8.3. Cath Labs
• 8.4. Hospitals

9. Americas Drug Eluting Balloon Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Drug Eluting Balloon Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Drug Eluting Balloon Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Advanced NanoTherapies (ANT) Secures USD 4 Million Strategic Investment to Accelerate Clinical Development of SirPlux Duo Drug-Coated Balloon (DCB) for Treating de novo Coronary Artery Disease (CAD)
  • 12.3.2. Translumina further Strengthens Its Technology Portfolio with Acquisition of Blue Medical Devices, Netherlands
  • 12.3.3. Surmodics Receives FDA Approval for the SurVeil Drug-Coated Balloon

Companies Mentioned

• 1. Medtronic PLC
• 2. Becton, Dickinson and Company
• 3. Boston Scientific Corporation
• 4. M.A. Med Alliance SA by Cordis Corporation
• 5. Eurocor Tech GmbH
• 6. Lepu Medical Technology
• 7. Invamed
• 8. Biotronik SE & Co. KG
• 9. Cook Medical, Inc.
• 10. Terumo Corporation
• 11. Cardionovum GmbH
• 12. SurModics, Inc.
• 13. Johnson & Johnson Services, Inc.
• 14. Balton Sp. z o. o.
• 15. B. Braun Melsungen AG
• 16. Bayer AG
• 17. Abbott Laboratories
• 18. Wellinq
• 19. Laborie Medical Technologies, Inc.
• 20. Concept Medical
• 21. Zylox-Tonbridge Medical Technology Co., Ltd.
• 22. Biosensors International Group, Ltd.
• 23. Koninklijke Philips N.V.
• 24. iVascular S.L.U.